Myomo

Myomo Total Assets

The Total Assets of Myomo (MYO) as of Nov 4, 2026 is 38.64 M USD. In the previous year, Total Assets was 42.24 M USD — a change of -8.54% (lower).

Total Assets

38.64 MUSD

YoY

-8.54%

Last updated:

Total Assets of Myomo is 2025 38.64 M USD. Total Assets of Myomo was 2024 42.24 M USD. It decreases by -8.54% lower compared to the previous year.

The Myomo Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
8.28 M USD
Jan 1, 2019
6.60 M USD
Jan 1, 2020
14.71 M USD
Jan 1, 2021
20.10 M USD
Jan 1, 2022
10.16 M USD
Jan 1, 2023
14.58 M USD
Jan 1, 2024
42.24 M USD
Jan 1, 2025
38.64 M USD
The Myomo Total Assets history
YEARTotal AssetsYoY
38.64 MUSD-8.54%
42.24 MUSD+189.71%
14.58 MUSD+43.49%
10.16 MUSD-49.43%
20.10 MUSD+36.61%
14.71 MUSD+122.92%
6.60 MUSD-20.32%
8.28 MUSD-40.74%
13.97 MUSD+742.75%
1.66 MUSD+9.90%
1.51 MUSD-50.45%
3.05 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Myomo Stock analysis

What does Myomo do? Myomo, Inc. generates revenue by selling its MyoPro product line, which consists of myoelectric-controlled upper limb braces designed for patients with neuromuscular disorders. The company directly sells these orthoses to patients and bills their insurance providers for coverage. The MyoPro enables users to control partially paralyzed limbs using their own muscle signals, supporting daily activities like eating and dressing. The target market includes adults and adolescents with conditions such as stroke, spinal cord injury, and brachial plexus injury. The MyoPro product line is marketed as a solution for functional improvement in upper limb paralysis, focusing on home and community use. Myomo’s devices are positioned to help patients regain independence in daily living tasks. Insurance reimbursement is a key revenue stream, with the company handling billing directly to insurers on behalf of patients. The primary customer segments are individuals with neuromuscular conditions requiring orthotic support for upper limb functionality. Myomo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Myomo stock

Total Assets of Myomo is 38.64 M USD in 2025.

Total Assets of Myomo changed from 42.24 M USD to 38.64 M USD, representing a -8.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Myomo since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Myomo historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Myomo

All Key Metrics — Myomo